Devonian Health Group is trading 9.4% down at CA$7.25 as investors unwind speculative gains following a sharp, news-light spike earlier in the week.
- The stock reached a high of CA$9.00 on July 9 before beginning a reversal that saw shares drop to CA$8.00 on July 10.
- With no fresh earnings, clinical, or regulatory announcements since late June, the move appears driven by profit-taking and a broader decline across the biotechnology sector.